You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 1, January 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE ANNUAL MEETING OF THE SOCIETY OF SURGICAL ONCOLOGY, NEW ORLEANS, MAY 22 TO MAY 25, 1988-Pa rt I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (66)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Nonpalpable In Situ Ductal Carcinoma of the Breast

Predictors of Multicentricity and Microinvasion and Implications for Treatment

Gordon F. Schwartz, MD; Arthur S. Patchefsky, MD; Sidney D. Finklestein, MD; Sae H. Sohn, MD; Anthony Prestipino, MD; Stephen A. Feig, MD; Jodi S. Singer, MD

Arch Surg. 1989;124(1):29-32.


Abstract

• Fifty breasts with nonpalpable ductal carcinoma in situ (DCIS) were examined for the presence of microinvasion, multicentricity, and number of involved ducts to see if the biopsy specimen could have predicted the findings in the remainder of the breast. When DCIS was an incidental finding, fewer ducts were involved and no evidence of either microinvasion or multicentricity was found. Solid and cribriform DCIS were rarely multicentric or microinvasive; micropapillary DCIS was often multicentric, rarely microinvasive; comedocarcinoma was more likely to be both microinvasive and multicentric. Ductal carcinoma in situ as an incidental finding may be treated by excision alone; papillary and micropapillary DCIS are best treated by therapy aimed at the entire breast, although axillary dissection may not be required. Therapy for comedocarcinomas should include the entire breast and the axillary nodes.

(Arch Surg 1989;124:29-32)



Author Affiliations

From the Departments of Surgery (Drs Schwartz, Sohn, and Singer), Pathology (Drs Patchefsky and Prestipino), and Radiology (Dr Feig), Jefferson Medical College; and the Department of Pathology, Hahnemann University (Dr Finklestein), Philadelphia. Dr Patchefsky is now with Hahnemann University, Philadelphia.


Footnotes

Accepted for publication Sept 2, 1988.

Read in part before the Annual Meeting of the Society of Surgical Oncology, New Orleans, May 23, 1988.

Reprint requests to 1015 Chestnut St, Suite 510, Philadelphia, PA 19107 (Dr Schwartz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Current Management of Patients with Ductal Carcinoma-in-Situ
Chabner et al.
The Oncologist 1997;2:76-82.
ABSTRACT | FULL TEXT  

Surgical Treatment of Ductal Carcinoma In Situ of the Breast: 10- to 20-Year Follow-up
Simpson et al.
Arch Surg 1992;127:468-472.
ABSTRACT  

Occult Breast Cancer Presenting With Axillary Metastases: Updated Management
Baron et al.
Arch Surg 1990;125:210-214.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.